Trial intelligence / Profile preview

Pazopanib for Unilateral Upper Extremity Lymphedema

NCT00827372Phase 2Completed

Start
Jan 2009
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pazopanib in lymphedema. Started Jan 2009; status: completed.

02

Drugs

pazopanib
03

Conditions

lymphedema

Beyond the preview

Go deeper on NCT00827372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00827372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call